# | Title | Journal | Year | Citations |
---|
1 | Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial | Lancet Neurology, The | 2017 | 589 |
2 | Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia | Lancet Neurology, The | 2020 | 210 |
3 | Pathophysiology, prevention, and treatment of medication overuse headache | Lancet Neurology, The | 2019 | 151 |
4 | The association between migraine and physical exercise | Journal of Headache and Pain | 2018 | 105 |
5 | Tension‐Type Headache – The Normal and Most Prevalent Headache | Headache | 2018 | 92 |
6 | Paracetamol use during pregnancy — a call for precautionary action | Nature Reviews Endocrinology | 2021 | 90 |
7 | Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study | Cephalalgia | 2020 | 74 |
8 | Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study | Journal of Neurology | 2011 | 69 |
9 | Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study | Brain | 2008 | 63 |
10 | CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine | Cephalalgia | 2010 | 49 |
11 | Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache | European Journal of Neurology | 2007 | 44 |
12 | Animal models of pain and migraine in drug discovery | Drug Discovery Today | 2017 | 37 |
13 | Verapamil and Cluster Headache: Still a Mystery. A Narrative Review of Efficacy, Mechanisms and Perspectives | Headache | 2019 | 35 |
14 | Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor | Neurological Research and Practice | 2020 | 35 |
15 | The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials | Journal of Headache and Pain | 2012 | 32 |
16 | The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura | American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | 2006 | 30 |
17 | Factors Associated With Primary Headache According To Diagnosis, Sex, and Social Group | Headache | 2016 | 25 |
18 | Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack | Stroke | 2019 | 24 |
19 | Reduction of Medication Costs After Detoxification for Medication‐Overuse Headache | Headache | 2013 | 23 |
20 | Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study | Journal of Headache and Pain | 2021 | 23 |
21 | Quality in the provision of headache care. 2: defining quality and its indicators | Journal of Headache and Pain | 2012 | 22 |
22 | Choroid plexus aquaporin 1 and intracranial pressure are increased in obese rats: towards an idiopathic intracranial hypertension model? | International Journal of Obesity | 2017 | 22 |
23 | The analgesic efficacy of morphine varies with rat strain and experimental pain model: implications for target validation efforts in pain drug discovery | European Journal of Pain | 2019 | 22 |
24 | Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache | Annals of Neurology | 2021 | 22 |
25 | Cerebrovascular effects of endothelin-1 investigated using high-resolution magnetic resonance imaging in healthy volunteers | Journal of Cerebral Blood Flow and Metabolism | 2020 | 21 |
26 | Disturbed sleep in cluster headache is not the result of transient processes associated with the cluster period | European Journal of Neurology | 2019 | 20 |
27 | Quality in the provision of headache care. 1: systematic review of the literature and commentary | Journal of Headache and Pain | 2012 | 19 |
28 | Effect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries | Pharmacological Reports | 2019 | 15 |
29 | No additive effect of combining sumatriptan and olcegepant in the GTN mouse model of migraine | Cephalalgia | 2021 | 15 |
30 | Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register | Journal of Headache and Pain | 2011 | 13 |
31 | PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine | Pain Management | 2021 | 12 |
32 | PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine | Journal of Headache and Pain | 2022 | 12 |
33 | More precise phenotyping of cluster headache using prospective attack reports | European Journal of Neurology | 2019 | 10 |
34 | Spinal GABAA receptors for pain control: back to the future? | British Journal of Anaesthesia | 2019 | 10 |
35 | The impact of obesity-related raised intracranial pressure in rodents | Scientific Reports | 2022 | 8 |
36 | Prostaglandins and prostaglandin receptor antagonism in migraine | Journal of Headache and Pain | 2013 | 7 |
37 | Are migraine endophenotypes needed? | Nature Reviews Neurology | 2016 | 6 |
38 | CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache | Journal of Headache and Pain | 2011 | 5 |
39 | Tritium labelling of PACAP‐38 using a synthetic diiodinated precursor peptide | Journal of Labelled Compounds and Radiopharmaceuticals | 2012 | 3 |
40 | EHMTI-0149. Low CSF hypocretin-1 levels are associated with cluster headache | Journal of Headache and Pain | 2014 | 3 |
41 | Restless legs syndrome is associated with increased risk of migraine | Cephalalgia Reports | 2018 | 3 |
42 | Spinal GABAA receptors for pain control—lost in translation? | Pain | 2018 | 3 |
43 | When to use frovatriptan in migraine? | Journal of Headache and Pain | 2011 | 2 |
44 | EHMTI-0163. Reduced neck and shoulder strength in patients with tension-type headache. A case control study | Journal of Headache and Pain | 2014 | 2 |
45 | Is Orally Inhaled Dihydroergotamine (DHE) Equivalent in Efficacy in Migraine to Intravenous DHE? | Headache | 2014 | 2 |
46 | Localization of TRPA1 channels and characterization of TRPA1 mediated responses in dural and pial arteries in vivo after intracarotid infusion of Na2S | Cephalalgia | 2020 | 2 |
47 | Disability caused by medication-overuse headache can be considerably reduced by detoxification. Results from multinational COMOESTAS study | Journal of Headache and Pain | 2013 | 1 |
48 | EHMTI-0160. New questionnaire – impact of migraine, tension-type headache and neck pain: a validation study | Journal of Headache and Pain | 2014 | 1 |
49 | EHMTI-0234. Glyceryl trinitrate provoked mast cell degranulation is secondary to the release of nitric oxide in vivo | Journal of Headache and Pain | 2014 | 1 |
50 | The Melanopsin-Mediated Pupillary Light Response Is Not Changed in Patients with Newly Diagnosed Idiopathic Intracranial Hypertension | Neuro-Ophthalmology | 2018 | 1 |